Literature DB >> 27336333

[Administration of Neovasculgen agent for treatment of a patient with neuroischaemic form of diabetic foot syndrome].

E P Burleva1, Yu V Babushkina2.   

Abstract

Presented herein is a case report concerning successful treatment of a patient with the neuroischaemic form of diabetic foot syndrome using Neovasculgen(®) agent. This case by salvage of the supporting leg could have been considered unpromising without the use of the methods of therapeutic angiogenesis. The use of Neovasculgen(®) made it possible to obtain an optimal result with rehabilitation of the patient and preserving the initial level of his quality of life.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27336333

Source DB:  PubMed          Journal:  Angiol Sosud Khir        ISSN: 1027-6661


  1 in total

1.  Pentoxifylline improves the quality of life in type-2 diabetes foot syndrome.

Authors:  Marwan Al-Nimer; Rawa Ratha; Taha Mahwi
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.